J L Marcus1, L B Hurley2, A Prasad3, J Zaroff3, D B Klein4, M A Horberg5, A S Go2, G N DeLorenze2, C P Quesenberry2, S Sidney2, J C Lo2, M J Silverberg2. 1. Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA. 2. Kaiser Permanente Division of Research, Oakland, CA. 3. Kaiser Permanente San Francisco Medical Center, San Francisco, CA. 4. Kaiser Permanente San Leandro Medical Center, San Leandro, CA. 5. Kaiser Permanente Mid-Atlantic Permanente Research Institute, Rockville, MD, USA.
Abstract
OBJECTIVES: We evaluated the association of HIV infection and immunodeficiency with acute coronary syndrome (ACS) recurrence, and with all-cause mortality as a secondary outcome, after hospitalization for ACS among HIV-infected and HIV-uninfected individuals. METHODS: We conducted a retrospective cohort study within Kaiser Permanente Northern California of HIV-infected and HIV-uninfected adults discharged after ACS hospitalization [types: ST-elevation myocardial infarction (STEMI), non-STEMI, or unstable angina] during 1996-2010. We compared the outcomes of ACS recurrence and all-cause mortality within 3 years, both overall by HIV status and stratified by recent CD4 count, with HIV-uninfected individuals as the reference group. Hazard ratios (HRs) were obtained from Cox regression models with adjustment for age, sex, race/ethnicity, year, ACS type, smoking, and cardiovascular risk factors. RESULTS: Among 226 HIV-infected and 86 321 HIV-uninfected individuals with ACS, HIV-infected individuals had a similar risk of ACS recurrence compared with HIV-uninfected individuals [HR 1.08; 95% confidence interval (CI) 0.76-1.54]. HIV infection was independently associated with all-cause mortality after ACS hospitalization overall (HR 2.52; 95% CI 1.81-3.52). In CD4-stratified models, post-ACS mortality was higher for HIV-infected individuals with CD4 counts of 201-499 cells/μL (HR 2.64; 95% CI 1.66-4.20) and < 200 cells/μL (HR 5.41; 95% CI 3.14-9.34), but not those with CD4 counts ≥ 500 cells/μL (HR 0.67; 95% CI 0.22-2.08), compared with HIV-uninfected individuals (P trend < 0.001). CONCLUSIONS: HIV infection and immunodeficiency were not associated with recurrence of ACS after hospitalization. All-cause mortality was higher among HIV-infected compared with HIV-uninfected individuals, but there was no excess mortality risk among HIV-infected individuals with high CD4 counts.
OBJECTIVES: We evaluated the association of HIV infection and immunodeficiency with acute coronary syndrome (ACS) recurrence, and with all-cause mortality as a secondary outcome, after hospitalization for ACS among HIV-infected and HIV-uninfected individuals. METHODS: We conducted a retrospective cohort study within Kaiser Permanente Northern California of HIV-infected and HIV-uninfected adults discharged after ACS hospitalization [types: ST-elevation myocardial infarction (STEMI), non-STEMI, or unstable angina] during 1996-2010. We compared the outcomes of ACS recurrence and all-cause mortality within 3 years, both overall by HIV status and stratified by recent CD4 count, with HIV-uninfected individuals as the reference group. Hazard ratios (HRs) were obtained from Cox regression models with adjustment for age, sex, race/ethnicity, year, ACS type, smoking, and cardiovascular risk factors. RESULTS: Among 226 HIV-infected and 86 321 HIV-uninfected individuals with ACS, HIV-infected individuals had a similar risk of ACS recurrence compared with HIV-uninfected individuals [HR 1.08; 95% confidence interval (CI) 0.76-1.54]. HIV infection was independently associated with all-cause mortality after ACS hospitalization overall (HR 2.52; 95% CI 1.81-3.52). In CD4-stratified models, post-ACSmortality was higher for HIV-infected individuals with CD4 counts of 201-499 cells/μL (HR 2.64; 95% CI 1.66-4.20) and < 200 cells/μL (HR 5.41; 95% CI 3.14-9.34), but not those with CD4 counts ≥ 500 cells/μL (HR 0.67; 95% CI 0.22-2.08), compared with HIV-uninfected individuals (P trend < 0.001). CONCLUSIONS:HIV infection and immunodeficiency were not associated with recurrence of ACS after hospitalization. All-cause mortality was higher among HIV-infected compared with HIV-uninfected individuals, but there was no excess mortality risk among HIV-infected individuals with high CD4 counts.
Authors: Daniel R Drozd; Mari M Kitahata; Keri N Althoff; Jinbing Zhang; Stephen J Gange; Sonia Napravnik; Greer A Burkholder; William C Mathews; Michael J Silverberg; Timothy R Sterling; Susan R Heckbert; Matthew J Budoff; Stephen Van Rompaey; Joseph A C Delaney; Cherise Wong; Weiqun Tong; Frank J Palella; Richard A Elion; Jeffrey N Martin; John T Brooks; Lisa P Jacobson; Joseph J Eron; Amy C Justice; Matthew S Freiberg; Daniel B Klein; Wendy S Post; Michael S Saag; Richard D Moore; Heidi M Crane Journal: J Acquir Immune Defic Syndr Date: 2017-08-15 Impact factor: 3.731
Authors: Daniel B Klein; Wendy A Leyden; Lanfang Xu; Chun R Chao; Michael A Horberg; William J Towner; Leo B Hurley; Julia L Marcus; Charles P Quesenberry; Michael J Silverberg Journal: Clin Infect Dis Date: 2015-01-16 Impact factor: 9.079
Authors: Robert W Yeh; Stephen Sidney; Malini Chandra; Michael Sorel; Joseph V Selby; Alan S Go Journal: N Engl J Med Date: 2010-06-10 Impact factor: 91.245
Authors: Matthew S Freiberg; Chung-Chou H Chang; Lewis H Kuller; Melissa Skanderson; Elliott Lowy; Kevin L Kraemer; Adeel A Butt; Matthew Bidwell Goetz; David Leaf; Kris Ann Oursler; David Rimland; Maria Rodriguez Barradas; Sheldon Brown; Cynthia Gibert; Kathy McGinnis; Kristina Crothers; Jason Sico; Heidi Crane; Alberta Warner; Stephen Gottlieb; John Gottdiener; Russell P Tracy; Matthew Budoff; Courtney Watson; Kaku A Armah; Donna Doebler; Kendall Bryant; Amy C Justice Journal: JAMA Intern Med Date: 2013-04-22 Impact factor: 21.873
Authors: Nina Friis-Møller; Peter Reiss; Caroline A Sabin; Rainer Weber; Antonella d'Arminio Monforte; Wafaa El-Sadr; Rodolphe Thiébaut; Stephane De Wit; Ole Kirk; Eric Fontas; Matthew G Law; Andrew Phillips; Jens D Lundgren Journal: N Engl J Med Date: 2007-04-26 Impact factor: 91.245
Authors: David Carballo; Cécile Delhumeau; Sebastian Carballo; Caroline Bähler; Dragona Radovanovic; Bernard Hirschel; Olivier Clerc; Enos Bernasconi; Dominique Fasel; Patrick Schmid; Alexia Cusini; Jan Fehr; Paul Erne; Pierre-Fréderic Keller; Bruno Ledergerber; Alexandra Calmy Journal: AIDS Res Ther Date: 2015-02-22 Impact factor: 2.250
Authors: Clay Bavinger; Eran Bendavid; Katherine Niehaus; Richard A Olshen; Ingram Olkin; Vandana Sundaram; Nicole Wein; Mark Holodniy; Nanjiang Hou; Douglas K Owens; Manisha Desai Journal: PLoS One Date: 2013-03-26 Impact factor: 3.240
Authors: Sanyog G Shitole; Mark H Kuniholm; David B Hanna; Thomas Boucher; Angel Y Peng; Cecilia Berardi; Tina Shah; Anna E Bortnick; Panagiota Christia; James Scheuer; Jorge R Kizer Journal: Atherosclerosis Date: 2020-08-27 Impact factor: 5.162